Marksans Pharma (BOM:524404) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Marksans Pharma ROE % Adjusted to Book Value?

Marksans Pharma's ROE % for the quarter that ended in Jun. 2024 was 17.19%. Marksans Pharma's PB Ratio for the quarter that ended in Jun. 2024 was N/A. Marksans Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.

Marksans Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Marksans Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma ROE % Adjusted to Book Value Chart

Marksans Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

23.02

13.56

11.40

10.04

4.95

Marksans Pharma Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	6.80	-	4.55	-

Competitive Comparison of Marksans Pharma's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, Marksans Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marksans Pharma's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's ROE % Adjusted to Book Value falls into.

Marksans Pharma ROE % Adjusted to Book Value Calculation

Marksans Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	16.47%	/	3.33
	=	4.95%

Marksans Pharma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	17.19%	/	N/A
	=	N/A

Marksans Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Marksans Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (BOM:524404) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

MARKSANS:India

Address

Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053

Website

http://www.marksanspharma.com

Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma Headlines

No Headlines